Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye diseases
Pharma
FDA approves Tenpoint's presbyopia combo treatment Yuvezzi
Tenpoint has scored an FDA approval for Yuvezzi, a treatment for presbyopia, a condition that makes it difficult to focus on nearby objects.
Kevin Dunleavy
Jan 29, 2026 8:01am
Lenz ups Vizz visibility with Sarah Jessica Parker DTC campaign
Jan 14, 2026 11:37am
Apellis reports 4% sales drop for eye disease med Syfovre
Jan 12, 2026 1:06pm
Outlook stock plummets as FDA again snubs wet AMD drug
Aug 28, 2025 10:55am
Manufacturing issues cause FDA to delay decisions on Eylea HD
Aug 20, 2025 2:32pm
Lenz's Vizz wins FDA approval to crack large presbyopia market
Aug 1, 2025 10:45am
